ARTICLE 7. Labeling and Advertisement [111926. - 111926.3.]

Cal. Health and Safety Code - HSC 7.

in effect

Cal. Health and Safety Code - HSC § 111926. Section 111926.

(a) A manufacturer, distributor, or seller of an industrial hemp product shall follow packaging, labeling, and advertising laws, including, but not limited to, Chapter 4 (commencing with Section 110290), and federal laws incorporated or applicable in this state, including, but not limited to, Sections 110100, 110340, 110371, 110380, 110382, and 110407 and shall not violate this part. (b) A manufacturer, distributor, or seller of an industrial hemp product shall not do any of the following: (1) Directly target advertising or marketing to children or to persons who are pregnant or breastfeeding. (2) Advertise or market on a billboard or similar advertising device located on an interstate highway or on a state highway that crosses the California border. (3) Advertise or market industrial hemp products in a manner intended to encourage persons under 21 years of age to consume industrial hemp products. (4) Publish or disseminate advertising or marketing that is attractive to children. (5) Advertise or market industrial hemp products on an advertising sign within 1,000 feet of a daycare center, school providing instruction in kindergarten or any of grades 1 to 12, inclusive, playground, or youth center. (c) Advertising or marketing placed in broadcast, cable, radio, print, or digital communications shall only be displayed where at least 70 percent of the audience is reasonably expected to be 18 years of age or older, as determined by reliable, up-to-date audience composition data. (d) A violation of this section shall be subject to the requirements, fines, and penalties of Section 26152.2 of the Business and Professions Code.

Cal. Health and Safety Code - HSC § 111926.2. Section 111926.2.

(a) An industrial hemp product that is a dietary supplement, food, or beverage shall not be distributed or sold in the state without packaging and labeling on the product that includes all of the following information: (1) A label, scannable barcode, internet website, or quick response (QR) code linked to the certificate of analysis of the final form product batch by an independent testing laboratory that provides all of the following information: (A) The product name. (B) The name of the product’s manufacturer, packer, or distributor, and their address and telephone number. (C) The batch number, which matches the batch number on the product. (D) The concentration of cannabinoids present in the product batch, including, at minimum, total THC and any marketed cannabinoids or ingredient, as required by the department in regulation. (E) The levels within the product batch of contaminants, as required in subdivision (c) of Section 111925.2. (2) The product expiration or best by date, if applicable. (3) A statement indicating that children or those who are pregnant or breastfeeding should avoid using the product prior to consulting with a health care professional about its safety. (4) A statement that products containing cannabinoids should be kept out of reach of children. (5) The following statement, “THE FDA HAS NOT EVALUATED THIS PRODUCT FOR SAFETY OR EFFICACY.” (b) The requirements of this section shall apply to products manufactured 90 days or more after the enactment of this section.

Cal. Health and Safety Code - HSC § 111926.3. Section 111926.3.

(a) An industrial hemp product that is a cosmetic shall not be distributed or sold in the state without packaging and labeling on the product that includes all of the following information: (1) A label, scannable barcode, internet website, or quick response (QR) code linked to the certificate of analysis of the final form extract or the final form product batch by an independent testing laboratory that provides all of the following information: (A) The product name. (B) The name of the product’s manufacturer, packer, or distributor, and their address and telephone number. (C) The batch number, which matches the batch number on the product. (D) The concentration of cannabinoids present in the product batch, including, at minimum, total THC and any marketed cannabinoids. (E) The levels within the product batch of contaminants, as required in subdivision (c) of Section 111925.2. (2) The product expiration or best by date, if applicable. (3) The following statement, “THE FDA HAS NOT EVALUATED THIS PRODUCT FOR SAFETY OR EFFICACY.” (b) The requirements of this section shall apply to products manufactured 90 days or more after the enactment of this section.

Source: CA Legislative Counsel Bulk DataURL: https://downloads.leginfo.legislature.ca.gov/pubinfo_2025.zipFetched: 6/27/2026